As Breast Cancer Awareness Month comes to a close, we’re sharing a final chemistry-driven breakthrough that reshaped treatment. In the 2000s, Trastuzumab emerged as a landmark therapy. By targeting the HER2 protein, it blocks cell signaling and triggers immune destruction of cancer cells. This innovation ushered in a new era of personalized, targeted cancer care that continues to guide oncology research today. | ChemDraw